Monthly News Roundup - August 2022

FDA Approves Auvelity, a Novel and Rapid-Acting Antidepressant 
In August, the FDA approved Auvelity (dextromethorphan and bupropion) extended-release tablets for the treatment of major depressive disorder (MDD) in adults. Auvelity, from...